[{"NetIncomeLoss_1_Q2_USD":-1000.0,"NotesPayableRelatedPartiesNoncurrent_0_Q2_USD":80000.0,"AssetsCurrent_0_Q2_USD":3379.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":25000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":1000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":3125000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"ProceedsFromRelatedPartyDebt_1_Q2_USD":80000.0,"DeferredCosts_0_Q2_USD":167736.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":3379.0,"SharesIssuedPricePerShare_0_Q2_USD":18.0,"NetCashProvidedByUsedInFinancingActivities_1_Q2_USD":3379.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_1_Q2_USD":3379.0,"FederalDepositInsuranceCorporationPremiumExpense_1_Q2_USD":250000.0,"BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_0_Q2_USD":3390063.0,"SaleOfStockPricePerShare_0_Q2_USD":10.0,"Assets_0_Q2_USD":171115.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"PreferredStockValue_0_Q2_USD":null,"PreferredStockSharesIssued_0_Q2_shares":0.0,"AdditionalPaidInCapital_0_Q2_USD":24641.0,"RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_1_Q2_USD":10000.0,"BusinessAcquisitionSharePrice_0_Q2_USD":9.2,"SaleOfStockNumberOfSharesIssuedInTransaction_1_Q2_shares":1875000.0,"LiabilitiesCurrent_0_Q2_USD":147115.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_0_Q2_USD":9.2,"IncreaseDecreaseInAccruedLiabilities_1_Q2_USD":1000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q2_USD":null,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1000.0,"StockholdersEquity_0_Q2_USD":24000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":0.0,"BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_0_Q2_pure":0.6,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":66115.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":171115.0,"NotesPayableRelatedPartiesClassifiedCurrent_0_Q2_USD":80000.0,"PaymentsOfFinancingCosts_1_Q2_USD":76621.0,"Ticker":"NUVB","CIK":"1811063","name":"PANACEA ACQUISITION CORP","OfficialName":"Nuvation Bio Inc. Class A Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1238973430.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20200814"}]